Pharmacokinetics and elimination of quetiapine, venlafaxine, and trazodone during pregnancy and postpartum.
Klier
Claudia M
CM
Mossaheb
Nilufar
N
Saria
Alois
A
Schloegelhofer
Monika
M
Zernig
Gerald
G
D000293:Adolescent; D014150:Antipsychotic Agents / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy / Q000378:metabolism; D003511:Cyclohexanols / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D003987:Dibenzothiazepines / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D049590:Postpartum Period / Q000378:metabolism; D011247:Pregnancy; D011256:Pregnancy Outcome; D011264:Pregnancy Trimesters / Q000378:metabolism; D000069348:Quetiapine Fumarate; D012893:Sleep Wake Disorders / Q000150:complications / Q000188:drug therapy / Q000378:metabolism; D014196:Trazodone / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D000069470:Venlafaxine Hydrochloride
D014150:Antipsychotic Agents; D003511:Cyclohexanols; D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate; D000069470:Venlafaxine Hydrochloride; D014196:Trazodone